Links to other
FDA Forces Fatal Chemo on Kids
Reprinted from Wired News
...continued from the Children with Cancer in Hospitals section of the home page:
Michael and Raphaele Horwin never imagined that trying to save their son's life might mean he'd be taken away from them. Two-year-old Alexander Horwin was diagnosed in 1998 with an aggressive form of malignant brain cancer called medullablastoma, which almost always kills children. Alexander underwent two surgeries to remove the tumor. The first one left him temporarily unable to walk and with optic nerve damage. After the second, he was tumor-free, but the disease threatened to return if he didn't receive treatment.
Doctors recommended a "state-of-the-art" chemotherapy treatment. It was the best they had to offer -- but it could also damage Alexander's heart, lungs, liver and kidneys, and lead to loss of hearing, small stature, infertility, another cancer, intellectual decline and death. Despite the chemotherapy -- quite possibly because of it -- Alexander died less than four months after beginning treatment. It wasn't until after Alexander died that the Horwins discovered that in addition to those horrors, various medical journals reported that it was also ineffective for young children.
"After Alexander passed away, my wife and I wanted to find out why our 2-1/2-year-old son died while receiving 'state-of-the-art' chemotherapy at a prestigious children's hospital," Michael Horwin said. "We researched the medical literature and what we discovered astonished and sickened us."
Throughout the '70s, '80s and '90s, doctors reported in various journals that the drug Alexander received caused seizures, dementia and death, and that it is a carcinogen. One experiment was shut down early because the children's tumors spread within five months. Still, according to FDA regulations, this treatment trumped an experimental treatment the Horwins wanted to use simply because the chemo (called CCG-9921) is FDA-approved -- for adult cancer. It is not, however, approved for the treatment of medullablastoma in small children. Oncologists are still recruiting children with medullablastoma to test CCG-9921. It's called "off-label" use of a drug, and it's common practice among physicians.
Why, then, couldn't the Horwins choose a different treatment -- one that wasn't linked to reports of devastating effects but did seem to have added years to some children's lives and possibly cured others?
Frenzied research had led the Horwins to Dr. Stanislaw Burzynski. His treatment seemed to be the most promising and least harmful. The Horwins found stories online of Burzynski's medullablastoma patients who were now healthy and had suffered few if any side effects. But even though Burzynski's treatment was part of an FDA-approved clinical trial, the doctor had to turn them away. According to the FDA, only patients who had tried an approved treatment that had failed (meaning the tumor had returned) qualified for Burzynski's treatment.
Burzynski's controversial "antineoplaston" treatment is made of peptides originally discovered in human urine and now manufactured synthetically. The Polish-born doctor -- the only doctor in the world who offers this therapy -- claims that these protein fragments "turn off" cancer genes.
"When we were reluctant to bring in Alexander for chemo, the oncologists wrote in his chart that a court order might be necessary so that they could forcibly take our son from us," Horwin said. "That scared us." The Horwins felt chemo was their only choice, and they were devastated. After eating healthy foods during her pregnancy, and making all of his baby food with organic ingredients, Raphaele Horwin held Alexander as doctors injected him with medication his parents knew would poison him. After only three months of treatment, Alexander reported feeling pain in his lower back and neck. A CT scan revealed he had 30 new tumors, and doctors gave him a few days to live. He died three weeks later.
The FDA regulation that prevented Alexander from receiving Dr. Burzynski's treatment is part of the Food, Drug, and Cosmetics Act. It has been upheld by various lawsuits and state codes. Critics of the requirement say the Horwins' experience is emblematic of a larger problem: Americans don't have the freedom to choose the health care that they and their physicians believe is best.
"Few Americans are aware that their treatment options, indeed their most personal medical choices, are regulated by the government and are seriously limited if they become ill," said Peter Chowka, an investigative journalist who has reported on alternative medicine for 25 years and served as a consultant for the National Institutes of Health's Office of Alternative Medicine. "Quite simply, there is very little freedom of therapeutic choice and only a half-hearted commitment to medical pluralism in this country."
Burzynski's and some other so-called "alternative" cancer treatments show encouraging signs in some patients, but they are effectively banned in favor of FDA-approved treatments that have gone through the rigorous and very expensive approval process. The FDA says the rules are in place for good reasons, including the need to protect Americans from charlatans who want to take advantage of desperate, dying patients, as well as to protect children from parents who would fall for such schemes.
If Burzynski had disregarded the rule and treated Alexander, he would have faced prison time, a hefty fine and loss of his medical license. "I am basically happy to treat all of these patients because we see good results of treatment," Burzynski said. "Unfortunately, my hands are tied up, and I certainly can't do anything about it unless the FDA will change their mind."
Return to the Children in Hospitals section of the Home Page